CV Sciences, Inc. Operating Lease, Right-of-Use Asset, Amortization Expense
CV Sciences, Inc. (CVSI) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $131.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-13
- CV Sciences, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $66.00K, a 10.00% increase year-over-year.
- CV Sciences, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $65.00K, a 25.00% increase year-over-year.
- CV Sciences, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $63.00K, a 75.00% increase year-over-year.
- CV Sciences, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $63.00K, a 687.50% increase year-over-year.
- CV Sciences, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $238.00K, a 95.08% increase from fiscal 2024.
- CV Sciences, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $122.00K, a 12.96% increase from fiscal 2023.
- CV Sciences, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $108.00K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $66.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $131.00K 10-Q · filed 2026-08-13 | $194.00K derived: sum of 3 quarters · filed 2026-08-13 | $257.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $65.00K 10-Q · filed 2026-05-15 | $128.00K derived: sum of 2 quarters · filed 2026-05-15 | $191.00K derived: sum of 3 quarters · filed 2026-05-15 | $251.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $126.00K derived: sum of 2 quarters · filed 2026-03-26 | $186.00K derived: sum of 3 quarters · filed 2026-08-13 | $238.00K 10-K · filed 2026-03-26 |
| 2025-09-30 | $63.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $123.00K derived: sum of 2 quarters · filed 2026-08-13 | $175.00K 10-Q · filed 2025-11-13 | $211.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $112.00K 10-Q · filed 2026-08-13 | $148.00K derived: sum of 3 quarters · filed 2026-08-13 | $156.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $52.00K 10-Q · filed 2026-05-15 | $88.00K derived: sum of 2 quarters · filed 2026-05-15 | $96.00K derived: sum of 3 quarters · filed 2026-05-15 | $146.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $44.00K derived: sum of 2 quarters · filed 2026-03-26 | $94.00K derived: sum of 3 quarters · filed 2026-03-26 | $122.00K 10-K · filed 2026-03-26 |
| 2024-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $58.00K derived: sum of 2 quarters · filed 2025-11-13 | $86.00K 10-Q · filed 2025-11-13 | $114.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $78.00K 10-Q · filed 2025-08-13 | $106.00K derived: sum of 3 quarters · filed 2025-08-13 | |
| 2024-03-31 | $28.00K 10-Q · filed 2025-05-14 | $56.00K derived: sum of 2 quarters · filed 2025-05-14 | ||
| 2023-12-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $108.00K 10-K · filed 2025-03-27 | ||
| 2023-09-30 | $80.00K 10-Q · filed 2024-11-14 |